Analysts Set Relay Therapeutics, Inc. (NASDAQ:RLAY) PT at $19.80
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been given an average rating of “Moderate Buy” by the ten analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month target price […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been given an average rating of “Moderate Buy” by the ten analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month target price […]
